Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes (RCT)

4 de fevereiro de 2016 atualizado por: Mohamed El-Sharkawy, Kasr El Aini Hospital
The primary purpose of this study is to compare the effects of two different methods of care during the second stage of labor for nulliparous women (coached versus uncoached pushing) on the length of the second stage and how this may affect maternal and neonatal outcome.

Visão geral do estudo

Descrição detalhada

The study was conducted on 434 primigravidae women admitted to Kasr El Ainy teaching Maternity Hospital for labor. The study will be done in the period between October 2015 and April 2016. The study will include 434 women with the diagnosis of the first stage of labor with at least cervical dilatation 4cm.

Ethical approval obtained and an informed consent will be taken from each patient after explaining the nature and scope of the study.

Methodology in details:

  1. Careful and detailed history taking regarding:

    • Personal history
    • Complaint.
    • History of present pregnancy.
    • Menstrual History.
    • Past history.
  2. Careful general examination.
  3. Abdominal examination.
  4. Local vaginal examination.
  5. Ultrasound examination.

Management of Cases:

Group (I)(Coached group):

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.

Group (II)(Uncoached group):

It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .

Patients admitted early in labor are subjected to active management of labor as follows:

Pelvic examination performed. Routine amniotomy performed and progress assessed. When dilatation is not increasing, a low dose protocol of oxytocin infusion will be started. Oxytocin diluted in the form of 5IU in 500 ml Ringer lactate making a concentration of nearly 1mu oxytocin/1ml Ringer solution. Infusion instituted at a rate of 1 -2 milliunit (15-30 drops) per minute and increased gradually in increments of 1 -2 milliunit per minute at 30 minutes interval, until at least three uterine contractions noted in a 10 minute period using cardio tocograph.

Assessment of each stage of labor was performed as follow:

  1. First stage of labor:

    It includes:

    • Duration of the first stage of labor.
    • Rate of cervical dilatation and foetal descent.
    • Adequacy of uterine contractions and documentation of labor dystocia.
    • Excess uterine activity consisted of uterine tachysystole, hypertonus or uterine hyperstimulation
  2. Second stage of labor:

    It includes:

    • Duration of the second stage.
    • Rate of the descent of foetus.
    • Monitoring of foetal heart rate every 5 minutes by sonicaid or continuous by CTG.
    • Use of mediolateral episiotomy.
    • Intervention will be considered either by instrumental delivery,fundal pressure or by CS If the second stage is prolonged more than 2 hours.
    • Monitoring of maternal oxygen saturation by pulse oximeter.
  3. Third stage of labor:

    - Duration of the third stage.

  4. Assessment of any vaginal laceration or perineal tears with their repair as well as repair of episiotomy.
  5. Assessment of quantity of blood loss and assessment of uterine atony(vital instability,number of soaked pads and hemoglobin drop) .
  6. Rate of caesarean section during varying stages of labor.
  7. Neonatal assessment:

It includes:

  • Foetal sex and body weight.
  • APGAR score at 1 and 5 minutes..

Tipo de estudo

Observacional

Inscrição (Antecipado)

434

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 35 anos (Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Fêmea

Método de amostragem

Amostra de Probabilidade

População do estudo

The study was conducted on 434 primigravidae women admitted to Kasr El Ainy teaching Maternity Hospital for labor. The study will be done in the period between October 2015 and April 2016. The study will include 434 women with the diagnosis of the first stage of labor with at least cervical dilatation 4cm.

Descrição

Inclusion Criteria:

All patients admitted in the first stage of labor with cervical dilatation of 4 cm at least:

  1. Women age 18-35 years.
  2. 37-41 weeks gestation pregnancy.
  3. Singleton pregnancy and vertex presentation.
  4. Women have no chronic or pregnancy-induced illnesses.
  5. Women are in established, spontaneous labor.

Exclusion Criteria:

  1. Malpresentation.
  2. Women with previous uterine scar.
  3. Multiple pregnancy
  4. Ante partum hemorrhage.
  5. Cephalopelvic disproportion.
  6. Women have chronic illnesses.
  7. Women with abnormal antenatal period.
  8. Patients with foetal distress
  9. Premature rupture of membrane
  10. Woman having any contraindication to vaginal delivery.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: Controle de caso
  • Perspectivas de Tempo: Prospectivo

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
1

Group (I)(Coached group):

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.
2
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth.
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Prazo
Duration of the second stage
Prazo: 0-3 hours
0-3 hours

Medidas de resultados secundários

Medida de resultado
Prazo
Severe maternal morbidity e.g post partum hemorrhage
Prazo: intrapartum and 2 hours postpartum.
intrapartum and 2 hours postpartum.
APGAR score after one and five minutes.
Prazo: 1-5 minutes
1-5 minutes

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Diretor de estudo: Kasr El Ainy, hospital, kasr el ainy street,cairo,egypt

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de novembro de 2015

Conclusão Primária (Antecipado)

1 de maio de 2016

Conclusão do estudo (Antecipado)

1 de maio de 2016

Datas de inscrição no estudo

Enviado pela primeira vez

20 de novembro de 2015

Enviado pela primeira vez que atendeu aos critérios de CQ

4 de fevereiro de 2016

Primeira postagem (Estimativa)

8 de fevereiro de 2016

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

8 de fevereiro de 2016

Última atualização enviada que atendeu aos critérios de controle de qualidade

4 de fevereiro de 2016

Última verificação

1 de fevereiro de 2016

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • KasrELAini maternity hospital

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever